The US Food and Drug Administration (FDA) has approved atezolizumab and hyaluronidase-tqjs (Tecentriq Hybreza, Genentech, Inc.) as a subcutaneous injection in adults, covering all approved indications ...
Tremfya is a brand-name drug used to treat moderate to severe plaque psoriasis, active psoriatic arthritis, moderate to severely active ulcerative colitis (UC), and Crohn’s disease. Tremfya is given ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results